Weill Cornell Medicine shared a post on LinkedIn:
“Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth, even if they have stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely monitor for cancer progression, according to new research.
In an analysis led by Weill Cornell Medicine and Duke University, researchers found that in some cases cancer progression was detected on scans even when PSA levels were undetectable.
‘We found that up to roughly 25% of patients had radiographic prostate cancer progression without any rise in PSA levels, and they had worse outcomes,’ said Dr. Cora Sternberg of Weill Cornell Medicine and NewYork-Presbyterian Hospital, who led the study with Dr. Andrew Armstrong of Duke Cancer Institute.
Full story: PSA Levels Alone May Not Reflect Prostate Cancer Growth.”
Other articles about Weill Cornell Medicine on OncoDaily.